Park Medi World IPO: Issue Date, Price, GMP, Review & Company Details

Park Medi World IPO: A Comprehensive Overview for Investors

Park Medi World Ltd, a growing player in the healthcare and diagnostic services space, is set to launch its Initial Public Offering (IPO), drawing significant interest from retail and institutional investors. The company has built a strong reputation for offering accessible, technology-driven healthcare solutions across diagnostics, pharmacy services, and medical consultancy. With the IPO, Park Medi World aims to strengthen its operational footprint, expand its network, and upgrade its technology infrastructure.

Park Medi World Limited is a leading private hospital chain in North India, operating 14 NABH-accredited multi-super specialty hospitals, primarily under the ‘Park’ brand, with a total bed capacity of approximately 3,000–3,250 beds. It is the largest private hospital chain in Haryana.

About Park Medi World Ltd

Park Medi World operates across multiple verticals of healthcare services, including:

• Diagnostic centres equipped with advanced imaging and pathology services

• Pharmacy services offering both online and offline fulfilment

• Consultation and telemedicine platforms

• Preventive healthcare packages tailored for corporates and individuals

The company’s mission is to build an integrated, patient-centric ecosystem that makes healthcare affordable, efficient, and accessible.

Park Medi World IPO Details

• Issue Size: ₹920 crore

• Price Band: ₹154 to ₹162 per equity share

• Face Value: ₹2 per share

• Components:

  • Fresh Issue: ₹770 crore (New shares, proceeds go to the company)

  • Offer for Sale (OFS): ₹150 crore (Shares sold by promoter Dr. Ajit Gupta)

• Minimum Bid (Retail): 92 shares (₹14,904 at the upper price band)

• Listing: BSE and NSE

• Tentative Listing Date: December 17, 2025

Objectives of the Issue (Fresh Issue Proceeds)

The net proceeds from the fresh issue will primarily be used for:

• Debt Repayment: Approximately ₹380 crore for repaying/prepaying borrowings.

• Capital Expenditure: Funding a new hospital under its subsidiary Park Medicity (NCR) and purchasing medical equipment.

• General Corporate Purposes and Unidentified Inorganic Acquisitions.

Business Strengths

Integrated Healthcare Ecosystem

Park Medi World offers comprehensive medical services ranging from tests and imaging to pharmacy and consultations, making it a one-stop solution.

Strong Focus on Technology

The company has invested in digital infrastructure, enabling faster diagnostics, online booking, home sample collection, and telemedicine.

Growing Presence in the Healthcare Market

With rising demand for affordable medical support, Park Medi World is widening its footprint across urban and semi-urban regions.

Diversified Revenue Model

Income is generated from diagnostics, pharmacy sales, consultation services, preventive care programmes, and digital healthcare tools.

Park Medi World Financial Snapshot (Key Figures)

Brokerage Views (Highlights)

• Positives: Strong EBITDA margins and Return on Net Worth (RoNW) compared to peers; Debt repayment will boost net profit margins; Reasonable valuation compared to listed peers; Proven acquisition-based expansion strategy; Strong position in North India/Haryana.

• Risks/Concerns: High geographic revenue concentration in Haryana (approx. 70%); High debtor days (due to reliance on government schemes); High doctor attrition rate (around 34%); Significant contingent liabilities (corporate guarantees are over 70% of net worth); Uneven revenue/profit growth in recent years.

Conclusion

Park Medi World Ltd is positioned to capture a growing share of the healthcare services market. The IPO represents an opportunity for investors to participate in the company’s next phase of expansion. With rising healthcare awareness and demand for organised diagnostic services, Park Medi World could benefit significantly in the years ahead.